机译:ERCC1 C8092A中的多态性预测了用顺铂的化疗治疗的转移性/复发性鼻咽癌的无进展存活
Department of Medical Oncology Sun Yat-Sen University Cancer Center 651st Dongfeng Road East;
Department of Medical Oncology Sun Yat-Sen University Cancer Center 651st Dongfeng Road East;
Department of Medical Oncology Sun Yat-Sen University Cancer Center 651st Dongfeng Road East;
Department of Medical Oncology Sun Yat-Sen University Cancer Center 651st Dongfeng Road East;
Department of Medical Oncology Sun Yat-Sen University Cancer Center 651st Dongfeng Road East;
Department of Medical Oncology Sun Yat-Sen University Cancer Center 651st Dongfeng Road East;
Department of Medical Oncology Sun Yat-Sen University Cancer Center 651st Dongfeng Road East;
Department of Molecular Diagnosis Sun Yat-Sen University Cancer Center Guangzhou China;
Department of Medical Oncology Sun Yat-Sen University Cancer Center 651st Dongfeng Road East;
Cisplatin-based chemotherapy; DNA repair; Metastatic/recurrent NPC; Polymorphisms;
机译:ERCC1 C8092A的多态性预测以顺铂为基础的化疗治疗转移性/复发性鼻咽癌的无进展生存期
机译:血浆爱泼斯坦-巴尔病毒DNA水平强烈预测了姑息化疗治疗的转移性/复发性鼻咽癌的存活率。
机译:血浆爱泼斯坦-巴尔病毒DNA水平强烈预测转移性/复发性鼻咽癌姑息性化疗的存活率
机译:多光子显微镜对高转移性鼻咽癌细胞的分化
机译:促进鼻咽癌转移进展的机制
机译:ERCC1 Cys8092Ala和XRCC1 Arg399Gln多态性可预测鼻咽癌根治性放疗后的无进展生存期
机译:ERCC1 Cys8092ala和XRCC1 arg399Gln多态性可预测鼻咽癌根治性放疗后的无进展生存期。